Evolent Health, Inc. Operating Income Loss

• Evolent Health, Inc. showed a decrease of -913.1% in Operating Income Loss from 2024 to 2025.
• This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2013 to 2025), Evolent Health, Inc.'s Operating Income Loss has declined by 1,838.7%.
• Historical annual values: Fiscal year 2025: -$410.14 million | Fiscal year 2024: -$40.49 million | Fiscal year 2023: -$71.21 million | Fiscal year 2022: $3.64 million | Fiscal year 2021: -$42.41 million | Fiscal year 2020: -$262.85 million | Fiscal year 2019: -$308.89 million | Fiscal year 2018: -$47.48 million | Fiscal year 2017: -$72.84 million | Fiscal year 2016: -$237.42 million | Fiscal year 2015: -$42.97 million | Fiscal year 2014: $0.00 | Fiscal year 2013: -$21.16 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026